Back

Oral P2Y12 inhibiting therapy in patients with acute coronary syndrome: finding the sweet spot

European Heart Journal

28 October 2022
Organised by: Logo
Read full article
ESC Journals History of Cardiology BASICS

Contributors

Mattia Galli
Mattia Galli

Author

Luis Ortega-Paz
Luis Ortega-Paz

Author

Dominick J Angiolillo
Dominick J Angiolillo

Author

University of Florida College of Medicine – Jacksonville Jacksonville , United States of America

You may be interested in
thumbnail
Congress Session
State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?
14 March 2025
thumbnail
Congress Presentation
Impact of potent P2Y12 inhibitors in adverse events reduction in diabetic patients with Acute Coronary Syndromes. An analysis from ACHILLES Registry.
2 September 2019
thumbnail
Congress Presentation
P2y12 inhibitors versus aspirin monotherapy for secondary prevention in patients with established atherosclerotic cardiovascular disease: a systematic review and meta-analysis
29 August 2026
thumbnail
Congress Presentation
Pre-treatment with P2Y12 inhibitors in acute myocardial infarction with cardiogenic shock
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources